Publications by authors named "Chencen Lin"

Claim this Profile
T
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.
Ziwei Luo, Chencen Lin, Chuwei Yu, Changxian Yuan, Wenyong Wu

Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma.
Chen-Hui Luo, Li-Hong Hu, Jie-Yang Liu, Li Xia, Li Zhou, Chen-Cen Lin

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor.
Haixia Liu, Qianglong Mi, Xinyu Ding, Chencen Lin, Linyi Liu

Eur J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis